MyHealthChecked (MHC) Competitors GBX 7.66 -0.10 (-1.23%) As of 11:57 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock MHC vs. AVO, RUA, SUN, POLX, BELL, MXCT, DEMG, SN, NIOX, and EKFShould you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Polarean Imaging (POLX), Belluscura (BELL), MaxCyte (MXCT), Deltex Medical Group (DEMG), Smith & Nephew (SN), NIOX Group (NIOX), and EKF Diagnostics (EKF). These companies are all part of the "medical devices" industry. MyHealthChecked vs. Its Competitors Advanced Oncotherapy RUA Life Sciences Surgical Innovations Group Polarean Imaging Belluscura MaxCyte Deltex Medical Group Smith & Nephew NIOX Group EKF Diagnostics Advanced Oncotherapy (LON:AVO) and MyHealthChecked (LON:MHC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment. Which has stronger valuation and earnings, AVO or MHC? MyHealthChecked has higher revenue and earnings than Advanced Oncotherapy. MyHealthChecked is trading at a lower price-to-earnings ratio than Advanced Oncotherapy, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdvanced OncotherapyN/AN/A-£32.60M-£0.07N/AMyHealthChecked£3.22M1.24-£1.04M-£3.76-2.04 Which has more risk & volatility, AVO or MHC? Advanced Oncotherapy has a beta of 0.06, meaning that its share price is 94% less volatile than the S&P 500. Comparatively, MyHealthChecked has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500. Does the media refer more to AVO or MHC? In the previous week, MyHealthChecked's average media sentiment score of 0.13 beat Advanced Oncotherapy's score of 0.00 indicating that MyHealthChecked is being referred to more favorably in the news media. Company Overall Sentiment Advanced Oncotherapy Neutral MyHealthChecked Neutral Is AVO or MHC more profitable? Advanced Oncotherapy has a net margin of 0.00% compared to MyHealthChecked's net margin of -11.06%. MyHealthChecked's return on equity of -12.80% beat Advanced Oncotherapy's return on equity.Company Net Margins Return on Equity Return on Assets Advanced OncotherapyN/A -67.34% -11.73% MyHealthChecked -11.06%-12.80%-8.18% Do insiders and institutionals have more ownership in AVO or MHC? 17.8% of Advanced Oncotherapy shares are owned by institutional investors. Comparatively, 0.7% of MyHealthChecked shares are owned by institutional investors. 47.5% of Advanced Oncotherapy shares are owned by insiders. Comparatively, 9.3% of MyHealthChecked shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryMyHealthChecked beats Advanced Oncotherapy on 7 of the 11 factors compared between the two stocks. Get MyHealthChecked News Delivered to You Automatically Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MHC vs. The Competition Export to ExcelMetricMyHealthCheckedMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£3.98M£2.60B£6.11B£2.57BDividend YieldN/A2.45%5.72%5.38%P/E Ratio-2.0414.5129.22493.23Price / Sales1.24129.34491.4898,997.00Price / Cash1.7815.9925.8227.90Price / Book0.533.8712.478.13Net Income-£1.04M£132.05M£3.32B£5.89B7 Day Performance11.75%2.12%1.87%-0.37%1 Month Performance-30.35%2.88%8.40%0.76%1 Year Performance-44.12%14.47%63.49%126.54% MyHealthChecked Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MHCMyHealthCheckedN/AGBX 7.66-1.2%N/A-39.3%£3.98M£3.22M-2.0416Gap UpAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.10-2.4%N/A-20.4%£6.89M£4.11M-2.6148Gap DownSUNSurgical Innovations GroupN/AGBX 0.58+0.9%N/A+2.7%£5.41M£11.92M-371.7980News CoveragePOLXPolarean ImagingN/AGBX 0.41+2.0%N/A-68.4%£4.93M£2.56M-408.0028Gap DownBELLBelluscuraN/AGBX 0.75flatN/AN/A£3.01M£1.80M-0.0624MXCTMaxCyteN/AGBX 1.62flatN/A-99.4%£1.72M£35.75M-4.0580Gap UpHigh Trading VolumeDEMGDeltex Medical GroupN/AN/AN/AN/A£187K£1.76M-0.1537Gap UpHigh Trading VolumeSNSmith & Nephew3.2342 of 5 starsGBX 1,346.50+0.4%GBX 1,379.33+2.4%+19.4%£14.76B£7.08B48.4818,452Analyst ForecastHigh Trading VolumeNIOXNIOX GroupN/AGBX 72.40-1.1%GBX 90+24.3%+8.8%£302.54M£46M5,792.0092EKFEKF DiagnosticsN/AGBX 27.50-2.0%N/A-6.7%£123.50M£50.22M2,037.04356News CoveragePositive News Related Companies and Tools Related Companies Advanced Oncotherapy Competitors RUA Life Sciences Competitors Surgical Innovations Group Competitors Polarean Imaging Competitors Belluscura Competitors MaxCyte Competitors Deltex Medical Group Competitors Smith & Nephew Competitors NIOX Group Competitors EKF Diagnostics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MHC) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyHealthChecked PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MyHealthChecked With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
